结核菌短突变H37Rv-S与减少的生长适应性更容易被宿主免疫系统识别
Jilin Dong1, Guilian Li2, Jiahao Wang3
1College of Life Sciences, Hebei University, 071002, Baoding, China; State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Research Unit of Proteomics & Research and Development of New Drug of Chinese Academy of Medical Sciences, Beijing Institute of Lifeomics, 102206, Beijing, China.
Microbial pathogenesis
|November 20, 2024
概括
研究人员发现了一个Mycobacterium结核病 (Mtb) 突变,H37Rv-S,具有减弱的毒性. 这种菌株表现出蛋白质表达的改变和宿主免疫反应的增加,为结核病的病原体提供了洞察力.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 结核菌 (Mycobacterium tuberculosis,Mtb) 导致结核病 (TB),这是一个全球性的健康问题.
- 了解mtb的毒性,持久性和发病性对于开发有效的治疗方法至关重要.
- 减弱的Mtb菌株对于研究细菌机制和宿主-病原体相互作用至关重要.
研究的目的:
- 描述一种新的Mtb突变,H37Rv-S,具有明显的表型特征.
- 使用蛋白质学研究H37Rv-S和野生型Mtb H37Rv之间的分子差异.
- 分析骨髓衍生巨细胞 (BMDMs) 中对H37Rv-S感染的宿主免疫反应.
主要方法:
- 基因组测序以确定H37Rv-S.中的突变.
- TMT-标记定量蛋白质组学来比较蛋白质表达特征.
- 用H37Rv-S和H37Rv感染BMDMs进行宿主反应分析.
- 表型特征包括生长速度,抗生素耐药性和体外生存测试.
主要成果:
- H37Rv-S表现出减弱的特征:体较短,殖民地较光滑,生长较慢,抗生素耐药性降低.
- 基因组分析显示,H37Rv-S.中的31个基因中有34个突变.
- 蛋白质组分析在H37Rv-S (716组) 和感染的BMDMs (115组) 中发现了显著的差异性蛋白质表达.
- 在phoP的一个框架转移突变导致了phoP/phoR系统和相关网络蛋白的失调.
- 在BMDM中,宿主蛋白质失调与免疫反应,亡和铁亡途径有关.
- H37Rv-S显示BMDM患者的存活率降低.
结论:
- H37Rv-S是一种已确认的减弱的Mtb菌株,具有缺陷的表型特征.
- 这项研究阐明了导致Mtb衰减和宿主免疫识别的分子差异.
- 研究结果为确定结核病预防和治疗的新治疗点提供了基础.
更多相关视频
相关概念视频
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis III
304
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
304


